Summary: Cancer Check Labs is partnering with Healthcode Medical to offer a blood test that screens for over 200 types of solid tumors, aiming to improve early cancer detection across Canada.
Takeaways:
- The partnership provides Canadians with access to a blood test that screens for over 200 types of cancer, aiding in early detection and potentially saving lives.
- Cancer remains a leading cause of death in Canada, with over 200,000 new cases expected in 2023, emphasizing the importance of advanced screening solutions.
- This collaboration aims to raise awareness about the benefits of early cancer screening, empowering Canadians to take proactive steps toward better health outcomes.
Cancer Check Labs, a company offering a screening test that screens for over 200 known types and subtypes of solid tumors from a single blood draw, announced its entry into the Canadian market in partnership with Healthcode Medical, a leader in innovative healthcare solutions.Â
Curbing Cancer in Canada
This collaboration aims to enhance early cancer detection services across Canada, providing individuals with the opportunity to catch cancer at its earliest stages.
In Canada, cancer remains one of the leading causes of death, with an estimated one in two Canadians expected to be diagnosed with cancer in their lifetime. In 2023 alone, over 200,000 new cases are anticipated, highlighting the urgent need for advanced screening solutions. Early detection is crucial, as it can significantly increase survival rates and improve the quality of life for patients.
“At Cancer Check Labs, our mission has always been to empower individuals with the knowledge and tools necessary for early detection,” says Sumit Rai, CEO of Cancer Check Labs. “By partnering with Healthcode Medical, we are thrilled to bring our innovative testing solutions to Canada. We believe that by providing accessible screening options, we can help Canadians live longer, healthier lives filled with more meaningful moments.”
About Healthcode Medical
Healthcode Medical has been at the forefront of enhancing patient care through technology and innovative services. Their commitment to improving health outcomes aligns perfectly with the goals of Cancer Check Labs.
“We are excited to partner with Cancer Check Labs to expand our offering of essential health services,” says Jan Venter, MD, co-founder of Healthcode Medical. “Together, we aim to raise awareness about the importance of early cancer screening. By catching cancer early, we can give individuals the chance to be present for life’s significant events—birthdays, graduations, and family gatherings.”
With this partnership, Cancer Check Labs and Healthcode Medical will work collaboratively to educate Canadians about the benefits of early screening and provide access to advanced testing technologies. By prioritizing early detection, the companies hope to empower individuals to take charge of their health and enjoy a full life surrounded by loved ones.